Prostaglandin E2 induced release of luteinizing hormone releasing factor (LRF)

Sergio Ojeda, J. E. Wheaton, S. M. McCann

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Prostaglandin E2 (PGE2) injected into the third ventricle (3rd V) of conscious ovariectomized rats bearing a permanent jugular cannula increased the percentage of plasma samples showing detectable immunoassayable LRF levels at 1, 3 and 5 min after injection. This percentage was small at 2 and 4 min. When plasma LRF and LH titers were measured in animals injected intraventricularly with PGE2 and decapitated 5 min later, both LRF and LH were significantly higher than control values of diluent injected animals. These results indicate that PGE2 is acting on the hypothalamus to induce release of LRF sufficient in magnitude to be detected by measuring this neurohormone directly in peripheral plasma.

Original languageEnglish (US)
Pages (from-to)283-287
Number of pages5
JournalNeuroendocrinology
Volume17
Issue number3
StatePublished - 1975
Externally publishedYes

Fingerprint

Luteinizing Hormone
Dinoprostone
Third Ventricle
Hypothalamus
Neurotransmitter Agents
Neck
Injections

ASJC Scopus subject areas

  • Endocrinology
  • Neuroscience(all)

Cite this

Prostaglandin E2 induced release of luteinizing hormone releasing factor (LRF). / Ojeda, Sergio; Wheaton, J. E.; McCann, S. M.

In: Neuroendocrinology, Vol. 17, No. 3, 1975, p. 283-287.

Research output: Contribution to journalArticle

Ojeda, Sergio ; Wheaton, J. E. ; McCann, S. M. / Prostaglandin E2 induced release of luteinizing hormone releasing factor (LRF). In: Neuroendocrinology. 1975 ; Vol. 17, No. 3. pp. 283-287.
@article{b89fdc8e2ff54d01b2ffa5cd376d7c3b,
title = "Prostaglandin E2 induced release of luteinizing hormone releasing factor (LRF)",
abstract = "Prostaglandin E2 (PGE2) injected into the third ventricle (3rd V) of conscious ovariectomized rats bearing a permanent jugular cannula increased the percentage of plasma samples showing detectable immunoassayable LRF levels at 1, 3 and 5 min after injection. This percentage was small at 2 and 4 min. When plasma LRF and LH titers were measured in animals injected intraventricularly with PGE2 and decapitated 5 min later, both LRF and LH were significantly higher than control values of diluent injected animals. These results indicate that PGE2 is acting on the hypothalamus to induce release of LRF sufficient in magnitude to be detected by measuring this neurohormone directly in peripheral plasma.",
author = "Sergio Ojeda and Wheaton, {J. E.} and McCann, {S. M.}",
year = "1975",
language = "English (US)",
volume = "17",
pages = "283--287",
journal = "Neuroendocrinology",
issn = "0028-3835",
publisher = "S. Karger AG",
number = "3",

}

TY - JOUR

T1 - Prostaglandin E2 induced release of luteinizing hormone releasing factor (LRF)

AU - Ojeda, Sergio

AU - Wheaton, J. E.

AU - McCann, S. M.

PY - 1975

Y1 - 1975

N2 - Prostaglandin E2 (PGE2) injected into the third ventricle (3rd V) of conscious ovariectomized rats bearing a permanent jugular cannula increased the percentage of plasma samples showing detectable immunoassayable LRF levels at 1, 3 and 5 min after injection. This percentage was small at 2 and 4 min. When plasma LRF and LH titers were measured in animals injected intraventricularly with PGE2 and decapitated 5 min later, both LRF and LH were significantly higher than control values of diluent injected animals. These results indicate that PGE2 is acting on the hypothalamus to induce release of LRF sufficient in magnitude to be detected by measuring this neurohormone directly in peripheral plasma.

AB - Prostaglandin E2 (PGE2) injected into the third ventricle (3rd V) of conscious ovariectomized rats bearing a permanent jugular cannula increased the percentage of plasma samples showing detectable immunoassayable LRF levels at 1, 3 and 5 min after injection. This percentage was small at 2 and 4 min. When plasma LRF and LH titers were measured in animals injected intraventricularly with PGE2 and decapitated 5 min later, both LRF and LH were significantly higher than control values of diluent injected animals. These results indicate that PGE2 is acting on the hypothalamus to induce release of LRF sufficient in magnitude to be detected by measuring this neurohormone directly in peripheral plasma.

UR - http://www.scopus.com/inward/record.url?scp=0016591929&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0016591929&partnerID=8YFLogxK

M3 - Article

VL - 17

SP - 283

EP - 287

JO - Neuroendocrinology

JF - Neuroendocrinology

SN - 0028-3835

IS - 3

ER -